AZ has an understated efficacy rate, so it's better than 'OK'. Maybe, but their and Oxford's testing has been such a mess, with more than one lie promulgated b

AZ has an understated efficacy rate, so it's better than 'OK'. Maybe, but their and Oxford's testing has been such a mess, with more than one lie promulgated by AZ in public claims (the blended efficacy based on an appalling Oxford mistake that suggested a better dosing that later didn't pan out), that I don't have much confidence in their current Phase III claims. Which date back to early December and haven't been publicly updated. Those are based on 4 trials in different countries, less than 6,000 each for the official 21 day apart dosing and a 70% efficacy claim.